The present study sought to answer two questions: 1) whether myofibroblast-restricted deletion of MRTF-A is sufficient to dampen renal fibrosis and 2) which downstream target(s) of MRTF-A in renal fibroblasts might mediate the profibrogenic effects of MRTF-A. The gene discussed is MRTFA; the disease is renal fibrosis.